OpenFilings
CytomX Therapeutics, Inc.
Form
8-K
Report Period
2026-11-05
Date Filed
2026-11-05
Time Filed
16:07:41
Document Analysis
Natural Language Processing
Recognized Type
Unidentified
Defined Term Format
Underlined
Italicized
Bold
Exhibits
8-K
CYTOMX Q3 2026 EARNINGS RELEASE_DRAFT_POST_AC_FOR APPROVAL
Filing on SEC Edgar